Answers are grounded in this paper and cite their sources.
Background Dengue infection is an endemic infectious disease and it can lead to dengue fever, dengue hemorrhagic fever, and/or dengue shock syndromes. Dengue NS2B/NS3 protease complex is essential for viral replication and is a primary target for anti-dengue drug development. In this study, a NS2B/NS3 protease inhibition assay was developed using AlphaScreen ® beads and was used to screen compounds for their protease inhibition activities. Methods The assay system utilized a known NS2B/NS3 peptide substrate, a recombinant of NS2B/NS3 protease with proprietary StrepTactin ® donor and nickel chelate acceptor beads in 384-well format. Results The optimized assay to screen for NS2B/NS3 protease inhibitors was demonstrated to be potentially useful with reasonable zʹ factor, coefficient variance and signal to background ratio. However, screening of synthesized thioguanine derivatives using the optimized AlphaScreen ® assay revealed weak NS2B/NS3 inhibition activities. Conclusion The AlphaScreen ® assay to screen for NS2B/NS3 protease inhibitors is potentially applicable for high throughput screening.
No takes yet. Share an insight, caveat, or question.
Abduraman et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: